Wordt geladen...
Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis
Several second-generation bisphosphonates (BPs) are approved in osteoporosis treatment. Efficacy and safety depends on potency of farnesyl pyrophosphate synthase (FPPS) inhibition, hydroxyapatite affinity, compliance and adherence. The latter may be influenced by frequency and route of administratio...
Bewaard in:
| Gepubliceerd in: | Int J Womens Health |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4274146/ https://ncbi.nlm.nih.gov/pubmed/25565901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S73944 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|